The levels of MXD1 mRNA transcripts ranked the lowest in colorectal cancer (13 studies), leukemia (8 studies), esophageal cancer (5 studies) and head and neck cancer (4 studies) (Fig. S3I–N). This evidence concerns the gene MXD1 and esophageal cancer.